1. Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis. Issue 4 (4th December 2017) Authors: Mettke, F.; Schlevogt, B.; Deterding, K.; Wranke, A.; Smith, A.; Port, K.; Manns, M. P.; Vogel, A.; Cornberg, M.; Wedemeyer, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 4(2018) Page Start: 516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗